Besides, we evaluated the risk scores of the HCC patients corresponding to different immune subtypes (C1: Wound Healing, C2: IFN-gamma Dominant, C3: Inflammatory, C4: Lymphocyte Depleted, C5: Immunologically Quiet, C6: TGF-beta Dominant) (Figure 11F). The gene discussed is IFNG; the disease is hepatocellular carcinoma.